ORIC Pharmaceuticals, Inc.
ORIC
$8.60
-$0.23-2.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M |
| Total Depreciation and Amortization | 1.19M | 1.22M | 1.20M | 1.19M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.13M | 22.74M | 20.27M | 18.33M | 15.05M |
| Change in Net Operating Assets | -974.00K | -5.46M | -2.74M | -2.50M | 1.65M |
| Cash from Operations | -110.88M | -110.97M | -116.54M | -120.23M | -115.01M |
| Capital Expenditure | -327.00K | -712.00K | -704.00K | -1.09M | -1.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -188.13M | -147.32M | -121.66M | 12.33M | 107.81M |
| Cash from Investing | -188.46M | -148.03M | -122.36M | 11.25M | 106.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 309.54M | 247.66M | 246.74M | 135.67M | 1.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.15M | -2.40M | -2.40M | -656.00K | -242.00K |
| Cash from Financing | 306.39M | 245.26M | 244.34M | 135.01M | 1.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.06M | -13.74M | 5.44M | 26.03M | -7.03M |